NCT Number: NCT06235099
Phase: PHASE3
Trial Summary: This is a prospective, open-label Phase 3 study to evaluate copper Cu 64 PSMA I&T injection for PET/CT imaging in patients with recurrent prostate cancer after radical prostatectomy or radiation ther – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Curium US LLC
Acronym: Solar-Recur
Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives